Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Vandendriessche

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Verhandelingen - Koninklijke Academie Voor Geneeskunde Van Belgie|November 24, 2004
[Recent developments in gene therapy]T Vandendriessche
Verhandelingen - Koninklijke Academie Voor Geneeskunde Van Belgie|March 21, 2008
Gene therapy for hemophilia "A" and "B": efficacy, safety and immune consequencesM Chuah, T Vandendriessche
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 11, 2006
Cellular and genetic therapies for haemophiliaD Lillicrap, T VandenDriessche, K High
Bulletin Et Memoires De L'Academie Royale De Medecine De Belgique|April 15, 2008
Gene therapy for haemophilia "A" and "B": efficacy, safety and immune consequencesM K L Chuah, T Vandendriessche
Journal of Thrombosis and Haemostasis : JTH|July 2, 2013
Gene therapy for hemophiliaM K Chuah, H Evens, T VandenDriessche
The Journal of Gene Medicine|March 28, 2001
Gene therapy for hemophiliaM K Chuah, D Collen, T VandenDriessche
Current Gene Therapy|July 12, 2002
Viral vector-mediated gene therapy for hemophiliaT VandenDriessche, D Collen, M K Chuah
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 8, 2018
Haemophilia gene therapy: From trailblazer to gamechangerH Evens, M K Chuah, T VandenDriessche
Haemophilia : the Official Journal of the World Federation of Hemophilia|October 14, 2004
Preclinical and clinical gene therapy for haemophiliaM K L Chuah, D Collen, T Vandendriessche
Human Gene Therapy|November 1, 1995
Development and analysis of retroviral vectors expressing human factor VIII as a potential gene therapy for hemophilia AM K Chuah, T VandenDriessche, R A Morgan
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Verhandelingen - Koninklijke Academie Voor Geneeskunde Van Belgie|November 24, 2004
[Recent developments in gene therapy]T Vandendriessche
Verhandelingen - Koninklijke Academie Voor Geneeskunde Van Belgie|March 21, 2008
Gene therapy for hemophilia "A" and "B": efficacy, safety and immune consequencesM Chuah, T Vandendriessche
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 11, 2006
Cellular and genetic therapies for haemophiliaD Lillicrap, T VandenDriessche, K High
Bulletin Et Memoires De L'Academie Royale De Medecine De Belgique|April 15, 2008
Gene therapy for haemophilia "A" and "B": efficacy, safety and immune consequencesM K L Chuah, T Vandendriessche
Journal of Thrombosis and Haemostasis : JTH|July 2, 2013
Gene therapy for hemophiliaM K Chuah, H Evens, T VandenDriessche
The Journal of Gene Medicine|March 28, 2001
Gene therapy for hemophiliaM K Chuah, D Collen, T VandenDriessche
Current Gene Therapy|July 12, 2002
Viral vector-mediated gene therapy for hemophiliaT VandenDriessche, D Collen, M K Chuah
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 8, 2018
Haemophilia gene therapy: From trailblazer to gamechangerH Evens, M K Chuah, T VandenDriessche
Haemophilia : the Official Journal of the World Federation of Hemophilia|October 14, 2004
Preclinical and clinical gene therapy for haemophiliaM K L Chuah, D Collen, T Vandendriessche
Human Gene Therapy|November 1, 1995
Development and analysis of retroviral vectors expressing human factor VIII as a potential gene therapy for hemophilia AM K Chuah, T VandenDriessche, R A Morgan
Pageof 4